89 results
8-K
EX-1.1
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Other Events
4:30pm
relating to the use, treatment, storage and disposal of hazardous or toxic substances or waste and protection of health and safety or the environment which
424B5
PRAX
Praxis Precision Medicines Inc
29 Mar 24
Prospectus supplement for primary offering
4:29pm
of generalized
S-1
PPR events at any assessment period versus baseline. Safety results were consistent with our prior Phase 1 dose escalation study
424B5
PRAX
Praxis Precision Medicines Inc
27 Mar 24
Prospectus supplement for primary offering
4:49pm
, in the number of generalized
S-1
PPR events at any assessment period versus baseline. Safety results were consistent with our prior Phase 1 dose
8-K
PRAX
Praxis Precision Medicines Inc
26 Mar 24
Other Events
7:01am
period versus baseline. Safety results were consistent with the Company’s prior Phase 1 dose escalation study of PRAX-628 and pharmacokinetic analysis
S-3
EX-1.2
s0wjj0oqr 3zj
5 Mar 24
Shelf registration
9:08am
8-K
EX-99.1
z0swq4ov0uguyp28tvu5
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-99.2
yau f8ahc
5 Mar 24
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
7:13am
8-K
EX-1.1
s76u8u
12 Jan 24
Other Events
5:23pm
8-K
EX-1.1
jgvjmj
7 Dec 23
Entry into a Material Definitive Agreement
5:23pm
8-K
EX-99.1
jn8ymijllawp
7 Nov 23
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results
7:35am
8-K
lytf02 gpq3qycm
2 Oct 23
Other Events
1:27pm
8-K
EX-99.2
oc8rhm
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
8-K
ujftjskinq10pzvw
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
8-K
EX-99.1
vuf15 8hbmdie
9 Aug 23
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial Results
8:27am
8-K
EX-1.1
8ivuk2
20 Jun 23
Other Events
7:02am
424B5
8mezdgs
20 Jun 23
Prospectus supplement for primary offering
6:02am